PTGX
Protagonist Therapeutics Inc
137.30$
-1.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.97 | 4.01 | 0.07 | 0.08 | 2.57 | 0.45 | 0.09 | 0.07 | 0.12 | 0.80 | 3.01 | 3.97 | |
| 0.01 | 0.01 | 0.01 | 0.01 | – | 0.01 | – | – | – | 0.01 | 0.01 | – | – | |
| -0.01 | 0.97 | 4.01 | 0.07 | 0.08 | 2.57 | 0.45 | 0.09 | 0.07 | 0.12 | 0.79 | 3.01 | 3.97 | |
| 0.52 | 0.47 | 0.53 | 0.55 | 0.58 | 0.53 | 0.57 | 0.58 | 0.63 | 0.73 | 0.66 | 0.59 | 2.47 | |
| 0.13 | 0.13 | 0.23 | 0.15 | 0.16 | 0.13 | 0.19 | 0.17 | 0.17 | 0.18 | 0.19 | 0.18 | 0.68 | |
| 0.65 | 0.60 | 0.76 | 0.70 | 0.75 | 0.66 | 0.76 | 0.75 | 0.80 | 0.91 | 0.85 | 0.77 | 3.14 | |
| -0.65 | 0.37 | 3.24 | -0.63 | -0.67 | 1.91 | -0.31 | -0.66 | -0.73 | -0.79 | -0.05 | 2.24 | 0.82 | |
| – | 0.04 | – | – | – | – | – | – | – | – | – | – | – | |
| -0.58 | 0.44 | 3.31 | -0.51 | -0.54 | 2.01 | -0.19 | -0.54 | -0.62 | -0.69 | 0.03 | 2.33 | 1.19 | |
| -0.01 | -0.07 | 0.05 | -0.01 | -0.01 | 0.03 | – | 0.00 | – | 0.01 | -0.02 | 0.03 | – | |
| -0.58 | 0.44 | 3.26 | -0.50 | -0.54 | 1.98 | -0.19 | -0.55 | -0.62 | -0.70 | 0.05 | 2.29 | 1.17 | |
| -0.56 | 0.46 | 3.32 | -0.49 | -0.53 | 2.02 | -0.18 | -0.54 | -0.61 | -0.68 | 0.04 | 2.33 | 1.20 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.